Online citations, reference lists, and bibliographies.
← Back to Search

Enhanced Growth Inhibition Of Metastatic Lung Tumors By Intravenous Injection Of ATRA-cationic Liposome/IL-12 PDNA Complexes In Mice

P. Charoensit, S. Kawakami, Y. Higuchi, F. Yamashita, M. Hashida
Published 2010 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Interleukin 12 (IL-12) is a proinflammatory cytokine with antitumor activity. All-trans–retinoic acid (ATRA) exerts antitumor effects by regulating a variety of gene expressions, including tumor necrosis factor receptor 1 (TNFR1), increases the number of TNFR1 and potentiates TNF-α-induced apoptosis in cancer cells. In this study, ATRA-incorporated cationic liposome (ATRA-cationic liposome)/IL-12 plasmid DNA (pDNA) complexes were prepared to improve therapeutic efficacy of cationic liposome/IL-12 pDNA complexes in a mouse model of metastatic lung tumor after intravenous injection. IL-12 production in lungs by ATRA-cationic liposome/IL-12 pDNA complexes was comparable with that by cationic liposome/IL-12 pDNA complexes. The number of metastatic tumor cells (colon26/Luc) was quantitatively evaluated by measuring luciferase activity. ATRA-cationic liposome/IL-12 pDNA complexes reduced the number of colon26/Luc cells and tumor nodules in lungs. ATRA-cationic liposome/IL-12 pDNA complexes significantly prolonged the survival time of mice, whereas cationic liposome/IL-12 pDNA only slightly prolonged it. ATRA-cationic liposome/IL-12 pDNA complexes increased the TNFR1 mRNA upregulation and the number of apoptotic cells in the lung. Moreover, reduced serum alanine transaminase (ALT) and aspartate transaminase (AST) activities were observed in mice treated with ATRA-cationic liposome/IL-12 pDNA complexes. These results suggest that intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes is an effective method for the treatment of lung metastasis in mice.
This paper references
10.1038/sj.gt.3301784
The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes
F. Sakurai (2002)
10.1089/10430349950016375
Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases.
S. Dow (1999)
10.1097/CJI.0b013e31805449a8
Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma
S. Boorjian (2007)
10.1016/S1359-6101(01)00032-6
Interleukin-12 in anti-tumor immunity and immunotherapy.
M. Colombo (2002)
10.1158/1078-0432.CCR-06-2894
Doxorubicin Directs the Accumulation of Interleukin-12–Induced IFNγ into Tumors for Enhancing STAT1–Dependent Antitumor Effect
Shiguo Zhu (2007)
10.1038/sj.onc.1203547
All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-κB, activated protein-1 and apoptosis in human lung cancer cells
S. Manna (2000)
10.1158/1078-0432.CCR-07-1165
Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin
D. Ravel (2008)
10.1016/j.ejpb.2008.09.005
Evaluation of proinflammatory cytokine production and liver injury induced by plasmid DNA/cationic liposome complexes with various mixing ratios in mice.
Y. Ito (2009)
10.1016/J.TOXLET.2004.01.010
Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE(2) release from mouse peritoneal macrophages and TNF-alpha release from rat peripheral blood mononuclear cells.
B. Kim (2004)
10.1111/j.1460-9568.1998.00313.x
Synergistic stimulation of MHC class I and IRF‐1 gene expression by IFN‐γ and TNF‐α in oligodendrocytes
C. Agresti (1998)
10.1146/annurev.nutr.24.012003.132407
Retinoic acid receptors and cancers.
D. Soprano (2004)
10.1177/019262339902700112
The Toxicology of Interleukin-12: A Review
B. Car (1999)
10.1016/0168-3659(89)90069-2
Surface characterization of biomaterials: B.D. Ratner (Ed.), Elsevier, Amsterdam, 1988, 344 pages, Dfl. 230.00, $121.05
G. Llanos (1989)
10.1002/0470025077.chap89
Differentiation therapy.
R. Lotan (1990)
10.1158/1078-0432.CCR-04-1020
Inhibition of Metastatic Tumor Growth in Mouse Lung by Repeated Administration of Polyethylene Glycol-Conjugated Catalase
K. Hyoudou (2004)
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma.
S. Boorjian (2007)
10.1111/j.1440-1746.1997.tb00388.x
All‐trans retinoic acid suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats
K. Motomura (1997)
Role of interferon-gamma in interleukin 12-induced pathology in mice.
B. Car (1995)
Blast crisis accompanied with occurrence of the point-mutational activation of N-ras proto-oncogene and the chromosomal abnormality inv(3q) in chronic myelogenous leukemia presenting thrombocytosis.
M. Okabe (1990)
10.1182/blood-2008-04-150250
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
M. Sanz (2009)
10.1006/CYTO.2000.0687
Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
A. Berger (2000)
10.1124/jpet.105.100669
Evaluation of Proinflammatory Cytokine Production Induced by Linear and Branched Polyethylenimine/Plasmid DNA Complexes in Mice
S. Kawakami (2006)
10.1046/J.1523-1755.1999.00576.X
Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells.
P. Datta (1999)
10.1016/j.cub.2007.12.042
Retinoic acid
Gonçalo C. Vilhais-Neto (2008)
10.1016/0092-8674(78)90008-9
The induction of differentiation in teratocarcinoma stem cells by retinoic acid
Sidney Strickland (1978)
10.1016/J.JCONREL.2005.10.030
Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes.
S. Kawakami (2006)
10.1021/JS9504494
Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach.
G. Osaka (1996)
10.1158/0008-5472.CAN-06-1690
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.
N. Mirza (2006)
10.1016/J.JCONREL.2005.09.017
Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes.
M. Nishikawa (2005)
10.1200/JCO.2006.08.1596
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
L. Adès (2006)
10.1002/jgm.1117
Incorporation of all‐trans retinoic acid into lipoplexes inhibits nuclear factor κB activation mediated liver injury induced by lipoplexes in mice
P. Charoensit (2008)
10.1167/IOVS.06-1040
Tumor Necrosis Factor-α–Induced Apoptosis in Murine Cytomegalovirus Retinitis
J. Zhou (2007)
10.1016/J.JCONREL.2006.08.025
Inhibition of pulmonary metastasis in mice by all-trans retinoic acid incorporated in cationic liposomes.
Sachiko Suzuki (2006)
10.1016/0928-4346(96)00295-2
Suppressive effects of all-trans retinoic acid on the lipopolysaccharide-stimulated release of tumor necrosis factor-α and nitric oxide by rat Kupffer cells in vitro
K. Motomura (1996)
10.1016/J.JCONREL.2006.08.002
Inhibition of peritoneal dissemination of tumor cells by single dosing of phosphodiester CpG oligonucleotide/cationic liposome complex.
Y. Kuramoto (2006)
Combination of local, non-viral IL12 gene therapy and systemic paclitaxel chemotherapy in a syngeneic ID8 mouse model for human ovarian cancer.
M. Janát-Amsbury (2006)
10.1182/BLOOD-2007-03-078576
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome.
A. Soriano (2007)
10.1182/blood-2008-07-168617
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
P. Montesinos (2009)
10.1007/S11912-002-0031-1
Management of acute promyelocytic leukemia
M. Tallman (2002)
10.1002/JPS.2600841102
Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes.
R. Mahato (1995)
10.1093/JNCI/82.15.1247
Taxol: a novel investigational antimicrotubule agent.
E. Rowinsky (1990)
10.1089/104303401300057405
Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes.
S. Loisel (2001)
10.1038/sj.onc.1206936
Retinoids in cancer therapy and chemoprevention: promise meets resistance
S. Freemantle (2003)
10.1046/J.1523-1755.2003.00219.X
Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
Susumu Oseto (2003)
Management of acute promyelocytic
MS Tallman (1990)
10.1111/J.1745-7254.2007.00657.X
N-acetylcysteine attenuates lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice.
H. Wang (2007)
10.1038/374546A0
CpG motifs in bacterial DNA trigger direct B-cell activation
Arthur M. Krieg (1995)



This paper is referenced by
10.3109/1061186X.2013.830310
Strategies on the nuclear-targeted delivery of genes
Jing Yao (2013)
10.1186/1476-7120-11-11
Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles
Zhiyi Chen (2013)
10.1517/17425247.2012.735658
Liposomal delivery of proteins and peptides
Janani Swaminathan (2012)
All-trans retinoic acid-incorporated nanoparticles of deoxycholic acid-conjugated dextran for treatment of CT 26 colorectal carcinoma cells
Y. I. Jeong (2013)
10.1074/jbc.M111.321836
Retinoic Acid Receptor α Mediates All-trans-retinoic Acid-induced Klf4 Gene Expression by Regulating Klf4 Promoter Activity in Vascular Smooth Muscle Cells*
J. Shi (2012)
10.1371/journal.pone.0030522
A WKYMVm-Containing Combination Elicits Potent Anti-Tumor Activity in Heterotopic Cancer Animal Model
S. D. Kim (2012)
10.1016/J.AJPS.2013.07.009
Application of cationic liposomes for delivery of nucleic acids
G. Shim (2013)
10.1002/smll.201803428
A Novel Self-Assembled Mitochondria-Targeting Protein Nanoparticle Acting as Theranostic Platform for Cancer.
Xin-Jie Zhu (2019)
10.1016/J.JDDST.2019.01.004
Effect of amide linkage of PEG-lipid conjugates on the stability and cytotoxic activity of goniodiol loaded in PEGylated liposomes
P. Charoensit (2019)
10.1002/adhm.201400304
Supramolecular hydrogels for long-term bioengineered stem cell therapy.
Junseok Yeom (2015)
10.3389/fphar.2018.00971
Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
M. Durymanov (2018)
10.5772/30084
Interleukin 12: Stumbling Blocks and Stepping Stones to Effective Anti-Tumor Therapy
H. Pegram (2012)
10.5772/1453
Advancements in Tumor Immunotherapy and Cancer Vaccines
H. Arnouk (2012)
10.3389/fimmu.2020.575597
Localized Interleukin-12 for Cancer Immunotherapy
K. G. Nguyen (2020)
10.1080/01635581.2012.687425
Hepatic Vitamin A Preloading Reduces Colorectal Cancer Metastatic Multiplicity in a Mouse Xenograft Model
E. Park (2012)
Polynucléotides codant pour l'interleukine 12 (il-12) et leurs utilisations
Joshua P. Frederick (2017)
10.1080/21691401.2017.1290647
Liposome-targeted delivery for highly potent drugs
Hassan Bardania (2017)
10.1016/j.jconrel.2014.06.001
Glycosylation-mediated targeting of carriers.
S. Kawakami (2014)
10.1007/s00262-014-1523-1
Interleukin 12: still a promising candidate for tumor immunotherapy?
W. Lasek (2014)
10.1007/978-3-319-46906-5
Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology
W. Lasek (2016)
10.1007/s10456-012-9295-8
Emerging biotechnological strategies for non-viral antiangiogenic gene therapy
C. Liu (2012)
10.1016/j.ijpharm.2011.10.057
Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells.
Kyu-Don Chung (2012)
10.2147/IJN.S40580
All-trans retinoic acid-incorporated nanoparticles of deoxycholic acid-conjugated dextran for treatment of CT26 colorectal carcinoma cells
Y. I. Jeong (2013)
10.1016/B978-0-12-394295-1.00025-1
Therapeutic Efficacy and Systemic Antitumor T Cell Immunity Induced by RheoSwitch-Regulated IL-12 Expression after Intratumoral Injection of Adenovirus Vector or Vector-Transduced Dendritic Cells
T. Chan (2014)
Nucleic acid delivery : biocompatible yet efficient platforms
M. I. Carlos (2015)
10.1007/978-3-319-46906-5_2
Antitumor Effects of IL-12 in Preclinical Studies
W. Lasek (2016)
10.1038/cr.2011.34
HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs
B. Zheng (2011)
Semantic Scholar Logo Some data provided by SemanticScholar